Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment

It is estimated that one third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). This astounding statistic, in combination with costly and lengthy treatment regimens make the development of therapeutic vaccines paramount for controlling the global burden of tuberculosis. U...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Sasha E., Baldwin, Susan L., Orr, Mark T., Reese, Valerie A., Pecor, Tiffany, Granger, Brian, Dubois Cauwelaert, Natasha, Podell, Brendan K., Coler, Rhea N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027321/
https://www.ncbi.nlm.nih.gov/pubmed/29795025
http://dx.doi.org/10.3390/vaccines6020030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027321/
https://www.ncbi.nlm.nih.gov/pubmed/29795025
http://dx.doi.org/10.3390/vaccines6020030

Ejemplares similares